Get ready for another action-packed weekend in Major League Soccer. From the East to the West and everywhere between, here is ...

Pressure is building on BP chief exec Murray Auchincloss (pictured) following reports that Elliott was disappointed with his ...

Morgans analyst Scott Power notes there's a risk-off sentiment among investors as ASX health stocks fall again this week.

Professor Julia Vorholt's work has changed how we think about plant health. Her innovative research on plant microbiomes ...

The third-place slot marked another return to form. Novo Nordisk’s Wegovy reclaimed the seat it held in December, backed by ...

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...

G LP-1 drugs containing semaglutide (the active ingredient in Ozempic and Wegovy) have exploded in popularity for their ...

Steward Partners Investment Advisory LLC boosted its position in Innovator U.S. Equity Power Buffer ETF – November (BATS:PNOV ...

Amgen (AMGN) gains traction with a 26% YTD rise, strong earnings, and a robust dividend. Analysts signal growth potential ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

The reigning MLS Cup champions are bottom of the league, so it's little wonder the Galaxy are tumbling down the order of ESPN ...